Radioactive “seed” implants are proving to be effective for patients with low- grade, low volume prostate tumors. The seeds deliver a higher dose of radiation while reducing the risk of complications to surrounding tissue.

The radioactive seeds are implanted into the prostate gland using ultrasound for guidance. The procedure is what is termed as “minimally invasive.”

The implants produce very targeted radiation exposure to the prostate with limited damage to surrounding tissues.

In some cases, the procedure can replace traditional external-beam radiation, which often requires multiple visits over a couple of months. Technology impacts not only the “seeds” used in the treatment, but it is also used to customize the actual mapping of the treatment plan tailored individually for each patient.

This innovative technique has proven to be very effective with patients who have a cancer that is contained within the prostate and is not very aggressive.